Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/23811Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Elisaf, M. S. | en |
| dc.contributor.author | Tsianos, E. | en |
| dc.contributor.author | Mavridis, A. | en |
| dc.contributor.author | Dardamanis, M. | en |
| dc.contributor.author | Pappas, M. | en |
| dc.contributor.author | Siamopoulos, K. C. | en |
| dc.date.accessioned | 2015-11-24T19:36:07Z | - |
| dc.date.available | 2015-11-24T19:36:07Z | - |
| dc.identifier.issn | 0931-0509 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/23811 | - |
| dc.rights | Default Licence | - |
| dc.subject | Adolescent | en |
| dc.subject | Adult | en |
| dc.subject | Aged | en |
| dc.subject | Biological Markers | en |
| dc.subject | Female | en |
| dc.subject | Hepacivirus/*immunology | en |
| dc.subject | Hepatitis Antibodies/*blood | en |
| dc.subject | Hepatitis B/transmission | en |
| dc.subject | Hepatitis B Antibodies/blood | en |
| dc.subject | Hepatitis B Surface Antigens/blood | en |
| dc.subject | Hepatitis C/transmission | en |
| dc.subject | Hepatitis C Antibodies | en |
| dc.subject | Humans | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Renal Dialysis/*adverse effects | en |
| dc.title | Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: association with hepatitis B serological markers | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/1717891 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1991 | - |
| heal.abstract | Hepatitis C virus (HCV) seems to be the main causative agent of the parenterally transmitted non-A, non-B hepatitis and the detection of anti-HCV may be a marker of ongoing infection with this virus. This study was undertaken to determine the frequency of anti-HCV in 51 haemodialysis patients of our renal unit. In addition association of these antibodies to sex, history of blood transfusions, and duration on haemodialysis, as well as to serological markers of hepatitis B virus infection, was applied. Enzyme-linked immunosorbent assay (ELISA), were used for the detection of all serological markers. Nine of the 51 (17.6%) haemodialysis patients had anti-HCV. The presence of anti-HCV was related to male sex. Although seropositive patients were transfused more often than seronegatives, this difference is not statistically significant. The presence of anti-HCV was associated with the duration of haemodialysis. The majority of anti-HCV patients had serological markers of previous HBV infection, in contrast to seronegative patients. | en |
| heal.journalName | Nephrol Dial Transplant | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
